The Perelman School of Medicine’s graduating class of 2026 celebrated Match Day on March 20, revealing the location of their residencies with a celebration among faculty, friends, and family.
1 min. read
Penn Medicine’s graduating class of 2026, moments after noon on March 20 in the Jordan Medical Education Center.
On Friday, March 20, around 150 students celebrated Match Day with a celebration, joined by faculty, friends, and family at the atrium in the Jordan Medical Education Center. For Perelman School of Medicine students, Match Day 2026 points the way to the next destination on their journey to practicing medicine.
This year, the graduating class of 2026 will see more than a quarter of its students remaining here in Philadelphia to complete their residency requirements at either the Hospital of the University of Pennsylvania or the Children’s Hospital of Philadelphia. And over one-third of the graduating class will remain in the Commonwealth. The top three specialties students are pursuing residencies in are internal medicine, pediatrics, and psychiatry.
When the Schuylkill swallowed the city: Lessons from Hurricane Ida’s historic flood
New Penn research shows that Hurricane Ida wasn’t a once-in-a-century anomaly but a preview of how climate change, urbanization, and aging infrastructure are rewriting flood risk.
The Fed explained: What it does and why it matters
Former Philadelphia Fed President Patrick Harker and financial historian Peter Conti-Brown, both Wharton professors, unpack the central bank’s origins, its unusual structure, and the quiet ways it shapes the economy
How population changes are impacting primary education worldwide
Research from Penn sociologist Emily Hannum and colleagues reveals regional trends in whether school-age populations are increasing, plateauing, or decreasing—and shows how different countries are responding.
A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.
Fighting oral cancer with bioengineered chewing gum
Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.
